People

POSITIONS:
Chief of Clinical Hepatology, San Francisco General Hospital
Director, Clinical and Translational Research in Hepatology, San Francisco General Hospital
Co-Director, UCSF Mentor Training Program
Director, UCSF T32 Hepatology Training Program

Ophir Klein is Professor of Orofacial Sciences and Pediatrics, the Larry L. Hillblom Distinguished Professor in Craniofacial Anomalies, and the Charles J. Epstein Professor of Human Genetics at the University of California, San Francisco (UCSF). He serves as Chief of the Division of Medical Genetics, Chair of the Division of Craniofacial Anomalies, Interim Director of the Institute for Human Genetics, and Director of the Program in Craniofacial Biology.

Dr. Arielle Klepper is a gastroenterologist and hepatologist. She received her MD and PhD from the Icahn School of Medicine at Mount Sinai, followed by internal medicine residency, chief residency, and gastroenterology fellowship at the University of California, San Francisco. Her clinical focus is in both gastroenterology and general hepatology, joining Drs. Courtney Sherman and Treveni Defries, as well as Davina Martinez, in the HALT clinic, focused on the treatment of patients with alcohol-associated liver disease.

Rebecca attended Medical School at the University Medical Center of the Johannes-Gutenberg University Mainz in Germany. She completed her Medical Doctoral Thesis through a joint project with the pediatric immunology and infectiology department at Mainz and the European Molecular Biology Laboratory (EMBL) in Heidelberg, focusing on the gut microbiome in children with inflammatory bowel disease.

Dr. Krauss' research program focuses on plasma lipoprotein metabolism and related traits that influence risk for coronary artery disease. His laboratory developed and applied methodology that led to the discovery of a common genetically-influenced atherogenic lipoprotein phenotype that underlies cardiovascular disease risk in patients with obesity, type 2 diabetes, and metabolic syndrome. A major current research emphasis has been the identification of genetic determinants of the wide range of inter-individual variability in phenotypic and clinical response to statin treatment.

Dr. Krogan was born and raised in Regina, Saskatchewan, Canada, obtained his undergraduate degree from the University of Regina and his PhD from the University of Toronto. Dr. Krogan’s lab at UCSF focuses on developing and applying quantitative, systematic proteomic and genetic approaches to study complex biological and biomedical problems. At present time, the Krogan group is focused on studying cancer, infectious disease and psychiatric disorders.